Programs | Appropriate VTE Prevention and Treatment Delivering Quality Care From the Inpatient to the Outpatient Setting

 View the VTE program here

A recent multinational survey based on acute care hospital chart reviews utilized AmericanCollege of Chest Physicians (ACCP) guidelines to assess the risk of developing venous thromboembolism (VTE). Survey results showed that less than half of at-risk medical patients received ACCP-recommended VTE prophylaxis, highlighting the important need for proactive identification of at-risk medical patients in acute care through stratification and institution of guideline-recommended preventive measures. In addition to inconsistent recognition and underutilization of appropriate preventive strategies, there are also important clinical needs concerning the treatment of VTE. For instance, the transition from the hospital environment to the home or other outpatient setting is a time when suboptimal management or gaps in communication can adversely impact outcomes. Recognizing these clinical gaps in patient care, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) responded by establishing prophylaxis and treatment of VTE as a safety priority in their currently published National Patient Safety Goals (NPSGs).

This program will assess important topics in VTE management, including methods to assess risk for deep-vein thrombosis (DVT), duration of VTE prophylaxis, and important issues relevant to the contemporary treatment of VTE.

• Identify hospitalized patients who are at risk for venous thromboembolic events
• Describe appropriate VTE prophylaxis and treatment based on current evidence-based recommendations
• Review JCAHO standards concerning VTE management and assess their clinical applications

This activity is intended for hospitalists, orthopedic surgeons, hematologists, intensivists, internists, family physicians, pharmacists, and nurses who treat patients with or at risk for VTE.

Panel Members

Satellite Broadcast

 Accreditation Information

SCEPTER is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

This activity has been reviewed and is acceptable for up to 1 Prescribed credit(s) by the American Academy of Family Physicians.

Global Education Group (Global) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.  Universal Activity Number 0530-9999-10-L01-P & 0530-9999-10-001-H01-P.

Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Disclosure of Conflicts of Interest

SCEPTER and Global Education Group (Global) require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have a related to the content of this activity.  All identified conflicts of interest are thoroughly vetted by Global and SCEPTER for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

This activity is jointly sponsored by SCEPTER^TM and Quintiles Medical Education.

This activity is co-provided by Global Education Group and SCEPTER^TM.

This activity is supported by an educational grant from sanofi aventis.

The opinions expressed in this program are those of the speaker and do not necessarily reflect the opinions or recommendations of the speaker's affiliated institutions, the publisher, SCEPTER^TM and Quintiles Medical Education, Global Education Group  and SCEPTER^TM (the accreditor), Sanofi Aventis (the commercial supporter), or CRM Healthcare.  Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients' conditions and possible contraindications or risks or without a review of any applicable manufacturer's product information and comparison with the recommendations of other authorities.